<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D6784BA3-960E-40CB-8663-A597913E4CF5"><gtr:id>D6784BA3-960E-40CB-8663-A597913E4CF5</gtr:id><gtr:firstName>D</gtr:firstName><gtr:surname>Higgs</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137961144"><gtr:id>8AD82DE9-4744-4F51-8405-2C353B8AF6BB</gtr:id><gtr:title>Structure and Regulation of the alpha Globin Cluster</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137961144</gtr:grantReference><gtr:abstractText>Haemoglobin is the protein contained in the bloods red cells that carries oxygen to important organs (e.g. heart, liver, kidneys, pancreas and brain). Abnormalities in this protein can cause anaemia, which can lead to the malfunction of the organs it normally supplies with oxygen. Each molecule of haemoglobin is made up of four interlocking parts; two called alpha units and two called beta units or chains. The chains are made in the body by two sets of genes, called the alpha and beta genes. Most peoples bodies make equal amounts of alpha and beta chains but in a form of anaemia, known as alpha thalassaemia, the alpha chains are under-produced. This condition is a result of genetic defects and is common in people originating from Southeast Asia and the Mediterranean. Research at the MRC Molecular Haematology Unit is aimed at understanding how these genes are normally regulated and what goes wrong with these genes in people with alpha thalassaemia. Current work is directed towards correcting the deficiency caused by these faulty genes.</gtr:abstractText><gtr:technicalSummary>At the present time we do not understand the mechanisms by which any mammalian gene is activated and regulated during differentiation and development. Clearly this involves the interaction of key cis-elements (e.g. enhancers, promoters and silencers) with trans-acting proteins (e.g. transcription factors, co-activators, adaptors and chromatin modifiers) that give rise to changes in gene expression which are associated with changes in epigenetic modification (methylation, replication, histone modification and nuclear position). We now need to understand the hierarchy and order of these events in gene regulation. We are studying expression of the a globin cluster in its natural chromosome environment during erythropoiesis as a model of mammalian gene expression. Our ultimate aim is to develop a comprehensive understanding of how mammalian genes are expressed from (or silenced within) their normal chromosomal environment and use this information to improve the management of patients with mutations in the globin genes that cause the human genetic disease thalassaemia. Ultimately any hypotheses about how the a globin genes are regulated have to be tested in experimental systems and at present this is achieved using interspecific hybrids in erythroid cells, stable transfectants of erythroid cells, transgenic mice and the use of ES cells to generate mice that have been modified using homologous recombination. We have recently developed a humanised mouse model that will allow us to study the human alpha cluster in a mouse background. Allowing functional studies that fully complement analysis of the transcriptional and epigenetic programmes. Over the past few years we have established high throughput assays to analyse all aspects of the transcriptional and epigenetic programmes controlling globin gene expression and we are now applying the principles learnt from globin to the entire human genome. Our ultimate aim is to develop a comprehensive understanding of how mammalian genes are expressed from their normal chromosomal environment and use this information to improve the management of patients with mutations in the globin genes that cause thalassaemia and related disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3337906</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Stem Cell Research Edinburgh</gtr:department><gtr:description>Generating a humanised mouse model of alpha globin expression</gtr:description><gtr:id>838A47CF-FD2E-4B47-8466-4AF49AE7DFAD</gtr:id><gtr:impact>High profile publication and acknowledgement of the field of the importance of such models for studying human disease.</gtr:impact><gtr:outcomeId>C2FDDB978F7-1</gtr:outcomeId><gtr:partnerContribution>Creating mice by homologous recombination</gtr:partnerContribution><gtr:piContribution>Scientific plan, creating mice by homologous recombination, analysis of mouse model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Week</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>98FFB7B7-9FFF-4CA0-A078-B33ECF2130BA</gtr:id><gtr:impact>Oxford Science week is held annually to an audience of scientists and the general public

Good feedback from schools</gtr:impact><gtr:outcomeId>5A1847C06A0</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Radcliffe Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1C7A7FEE-8B50-44DC-9A30-7DA58D12C5EB</gtr:id><gtr:impact>XX</gtr:impact><gtr:outcomeId>58b96a59b408c2.31157978</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Fellowship</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>9DD36218-F9DC-4D95-B4AB-35F4BBD0C8BF</gtr:id><gtr:outcomeId>0AA1BD118DF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council Public Engagement</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8078ABB9-CB66-457E-95A4-5350ED82F416</gtr:id><gtr:outcomeId>56d6f7dca82018.91263813</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>265927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Training Fellowship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E43FA282-ECC6-4E53-865C-FDED19E61BEC</gtr:id><gtr:outcomeId>56d6feac952ab9.09417202</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences starter grant</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>BCBFB1CD-A488-4AF9-A9AA-035B98D02334</gtr:id><gtr:outcomeId>56d6f90197d2f9.46424567</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242047</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Training Fellowship in Biomedical &amp;amp; Clinical Sciences</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3DFB33DC-F268-485C-B290-5B0BC59FE80A</gtr:id><gtr:outcomeId>56d6f2b9181852.77197479</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>172229</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action Medical Research Project Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>4BA13EA8-7D06-4326-9E6B-5F453C8E989E</gtr:id><gtr:outcomeId>56d6f886df69a7.59025835</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150135</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust ISSF Single Cell Biology in Oxford</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>16FC4D39-D768-4D80-A0AB-379AA713A99C</gtr:id><gtr:outcomeId>56d6f479b07f03.39810950</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Henry Wellcome postdoctoral Fellowship</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E438F2E3-7A5A-42D6-8071-D5C3B08F0E44</gtr:id><gtr:outcomeId>56d6f8c47755f9.85529614</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2664612</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3CD9D68C-04CF-404C-84AA-27B7420D7E1A</gtr:id><gtr:outcomeId>56d6f84a7172f7.37040358</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>E P A Cephalosporin Fund</gtr:department><gtr:description>EPA Cephalosporin Fund</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>4150A5BF-DC36-4300-B306-0F2DEE2EAF7F</gtr:id><gtr:outcomeId>56d6f9b0416747.10800371</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>223480</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>16E39DFD-1369-4019-ADC5-0B08FCA7F456</gtr:id><gtr:outcomeId>56d6f30744ec47.26280480</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>917526</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institute of Health USA</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>2AFB9194-E6D4-469C-AF62-564F7FF09B8E</gtr:id><gtr:outcomeId>56d6f968abdbe7.29237019</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>44639</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>VISION</gtr:description><gtr:end>2021-07-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>67C97AFF-1A89-46F6-BE75-A21C60BF67A5</gtr:id><gtr:outcomeId>58b82bb38a87b5.22451850</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161117</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Four Year Phd Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>31388F57-3291-4A8B-9D9A-7B0B4CA4A596</gtr:id><gtr:outcomeId>56d6f812b50e63.41748809</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The IP covers the Next Generation Capture-C method for massively multiplexed 3C analysis of genome interactions</gtr:description><gtr:grantRef>MC_U137961144</gtr:grantRef><gtr:id>99D723B7-5366-43D7-B529-3820A373C5FF</gtr:id><gtr:impact>None so far</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b82e1c2e1e38.60695333</gtr:outcomeId><gtr:patentId>PCT/GB2016/053314</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>NG Capture C</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to the generation of transgenic animal cells and/or animals in which a large proportion of a host animal's genome has been replaced with an equivalent syntenic portion of nucleic acid from the genome of a different organism.</gtr:description><gtr:grantRef>MC_U137961144</gtr:grantRef><gtr:id>121DC441-A030-4899-940F-3AF65A274823</gtr:id><gtr:impact>European patent applied for</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>5A935612EB2</gtr:outcomeId><gtr:patentId>EP2099289</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Humanisation of Animals</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>As described in Wallace et al Cell 2005</gtr:description><gtr:grantRef>MC_U137961144</gtr:grantRef><gtr:id>DCAB1DA8-EB69-47AD-B65A-EB452158E2AC</gtr:id><gtr:impact>No impact as yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b82dc12a5a59.06050657</gtr:outcomeId><gtr:patentId>EP2099289</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Humanisation of Animals</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A model in which the mouse alpha globin cluster was replaced in its entirety by the human alpha globin cluster.</gtr:description><gtr:id>CF6B4C94-F506-4CB2-9BDA-E9B28558D869</gtr:id><gtr:impact>Opened up many new possibilities for research</gtr:impact><gtr:outcomeId>61B5050F620</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Humanised mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A model in which the mouse alpha globin cluster was replaced in its entirety by the human alpha globin cluster</gtr:description><gtr:id>E5D55A39-7961-4BF9-B486-B74372024E4F</gtr:id><gtr:impact>Opened up many new possibilities for research.</gtr:impact><gtr:outcomeId>DC8A09F6868</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Humanised mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0AEEA4E0-8EB7-4A21-921C-90C5B52940DF</gtr:id><gtr:title>Association between active genes occurs at nuclear speckles and is modulated by chromatin environment.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5972aac6e4f4128eb96dcaf53080fb8"><gtr:id>b5972aac6e4f4128eb96dcaf53080fb8</gtr:id><gtr:otherNames>Brown JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>7CE411F875F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C730B6E-5660-495F-8810-A3B364DCC0C7</gtr:id><gtr:title>Evidence of genetic heterogeneity in congenital dyserythropoietic anaemia type I.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6109abc8918bd3707eccb11a639910b3"><gtr:id>6109abc8918bd3707eccb11a639910b3</gtr:id><gtr:otherNames>Ahmed MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>C408196885A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09258931-3E57-4A91-91A6-A1AE14CAB7D3</gtr:id><gtr:title>Tissue-specific CTCF-cohesin-mediated chromatin architecture delimits enhancer interactions and function in vivo.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e3320b997585e7ad96855a15436f7db"><gtr:id>3e3320b997585e7ad96855a15436f7db</gtr:id><gtr:otherNames>Hanssen LLP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>5a994893de3972.98665193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CAD6C46-807B-426B-982A-C9F796DDA4A2</gtr:id><gtr:title>How transcriptional and epigenetic programmes are played out on an individual mammalian gene cluster during lineage commitment and differentiation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0067-8694</gtr:issn><gtr:outcomeId>8A2A84256FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5136F79-CC28-435A-9C01-F5D1D55EEB44</gtr:id><gtr:title>Elderly survivors with homozygous sickle cell disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/197d162ed5e2848442a26a7594a076b5"><gtr:id>197d162ed5e2848442a26a7594a076b5</gtr:id><gtr:otherNames>Serjeant GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>B5D1EDF5D6A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD2DF71-6EAF-4AF8-8FEA-E14510F1A1D3</gtr:id><gtr:title>The changing face of homozygous sickle cell disease: 102 patients over 60 years.</gtr:title><gtr:parentPublicationTitle>International journal of laboratory hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/197d162ed5e2848442a26a7594a076b5"><gtr:id>197d162ed5e2848442a26a7594a076b5</gtr:id><gtr:otherNames>Serjeant GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1751-5521</gtr:issn><gtr:outcomeId>13F5EC93C29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68B74AB6-469F-4556-9D21-BAB82D6D4D3D</gtr:id><gtr:title>Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f62bfcd0794a3cefbe9cae3c12f1a73e"><gtr:id>f62bfcd0794a3cefbe9cae3c12f1a73e</gtr:id><gtr:otherNames>Vernimmen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>47FAEC78B3B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37366BE9-6CB4-4255-90CD-7E2E6B94F1EE</gtr:id><gtr:title>Switching genes on and off in haemopoiesis.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b62f919c1ce48564e23cc6ba86f4ad99"><gtr:id>b62f919c1ce48564e23cc6ba86f4ad99</gtr:id><gtr:otherNames>Garrick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>9B1241CEF19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F282D35D-22C5-46D9-99D9-33BD266FBA3B</gtr:id><gtr:title>Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfec82673c7594058286be4e6cab89f"><gtr:id>ebfec82673c7594058286be4e6cab89f</gtr:id><gtr:otherNames>Wallace HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>27ED271B585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B1DFA79-CCD3-440F-BBE4-5E1F5137503E</gtr:id><gtr:title>Phenotypic and molecular characterization of a serum-free miniature erythroid differentiation system suitable for high-throughput screening and single-cell assays.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>5a6792b05d63d2.24437910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>741B8281-2DD4-4D9D-9D28-1EF10C57A9CA</gtr:id><gtr:title>Haemoglobin Variant Screening in Jamaica: Meeting Student's Request.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e6fd9fb38995a694e6e0235e807ea2a"><gtr:id>2e6fd9fb38995a694e6e0235e807ea2a</gtr:id><gtr:otherNames>Mason K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>56d03d3bab9875.64868857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1C44ABB-CEC5-4B30-BF96-B4D80379C4E1</gtr:id><gtr:title>An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83eaa97aba73c726e5a7cf1d92e9ab36"><gtr:id>83eaa97aba73c726e5a7cf1d92e9ab36</gtr:id><gtr:otherNames>Blobel GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>56d03d3bdb01c9.50490020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92EB725F-6F50-4770-BD5D-FF8D3257E439</gtr:id><gtr:title>DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ffbea2f52026736aa58c3be290fa8d5"><gtr:id>4ffbea2f52026736aa58c3be290fa8d5</gtr:id><gtr:otherNames>Jeziorska DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a99489398e3d0.82961220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E86A358-13B6-4FA2-9B95-6B6D9CE5CE80</gtr:id><gtr:title>Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function.</gtr:title><gtr:parentPublicationTitle>American journal of hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c29506e7798f39464c9733338f42caf"><gtr:id>9c29506e7798f39464c9733338f42caf</gtr:id><gtr:otherNames>dos Santos CO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0361-8609</gtr:issn><gtr:outcomeId>0E34C1B4D14</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>208F4917-992E-498A-98E1-1487BCFE264E</gtr:id><gtr:title>ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/461341f86b0010ce65b9c4daceda43e8"><gtr:id>461341f86b0010ce65b9c4daceda43e8</gtr:id><gtr:otherNames>Voon HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d03d3b30d975.84281615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FA69E77-B013-4EDD-A7D6-5FCDC2F4DE19</gtr:id><gtr:title>Molecular Basis and Genetic Modifiers of Thalassemia.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>5a994892d59272.68598540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>665A752F-E5E1-4B55-A576-60F67D2610BD</gtr:id><gtr:title>Between form and function: the complexity of genome folding.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a99489312a410.46080668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D9798D-4ADC-470D-8C17-619A667BD46B</gtr:id><gtr:title>A large deletion in the human alpha-globin cluster caused by a replication error is associated with an unexpectedly mild phenotype.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cec8ce691677098082a55d2063a9527"><gtr:id>5cec8ce691677098082a55d2063a9527</gtr:id><gtr:otherNames>Rugless MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>B2A42E7AA86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF019F92-8D63-4467-9BD6-552325F45B89</gtr:id><gtr:title>How best to identify chromosomal interactions: a comparison of approaches.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69710e756a65a120cb06d94fec106efb"><gtr:id>69710e756a65a120cb06d94fec106efb</gtr:id><gtr:otherNames>Davies JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>5a994894880936.79956951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27DA9727-21DE-494B-BAD4-07D29331D17A</gtr:id><gtr:title>Studying epigenomics in single cells: what is feasible and what can we learn?</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>56d03d3ca47976.64575634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E236801-601A-4861-88BA-03FB5E6B5437</gtr:id><gtr:title>Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f02c021074de23ceff430d6ed7c73ada"><gtr:id>f02c021074de23ceff430d6ed7c73ada</gtr:id><gtr:otherNames>Masuda T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56d03d3d0b0969.96461775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B314F026-75B9-47A3-84DF-BAEDEF737A6A</gtr:id><gtr:title>The role of the polycomb complex in silencing alpha-globin gene expression in nonerythroid cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b62f919c1ce48564e23cc6ba86f4ad99"><gtr:id>b62f919c1ce48564e23cc6ba86f4ad99</gtr:id><gtr:otherNames>Garrick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>634051005A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD100008-49B9-40ED-8D6D-DD557260271A</gtr:id><gtr:title>Genetic dissection of the a-globin super-enhancer in vivo.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4372a7f2d5ea1d6313b49e5c539a538"><gtr:id>f4372a7f2d5ea1d6313b49e5c539a538</gtr:id><gtr:otherNames>Hay D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b6af648844e9.80201951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C47672-6BB4-44CC-B358-7E56F2B8733E</gtr:id><gtr:title>Kr&amp;uuml;ppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09541d5782fbcf282cf795127548298"><gtr:id>b09541d5782fbcf282cf795127548298</gtr:id><gtr:otherNames>Perkins A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d03d3d6e8c52.23039500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8FE813B-FEBE-4154-B8CF-E78024F75D9B</gtr:id><gtr:title>A protocol for high-throughput phenotyping, suitable for quantitative trait analysis in mice.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4e2f41f194314a5657b74bc9845dfff"><gtr:id>b4e2f41f194314a5657b74bc9845dfff</gtr:id><gtr:otherNames>Solberg LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>45800A36170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E83C0303-1A34-4C21-9ADA-796A764FB058</gtr:id><gtr:title>A novel deletion causing alpha thalassemia clarifies the importance of the major human alpha globin regulatory element.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92d22eef053522284356ca6d29e0e206"><gtr:id>92d22eef053522284356ca6d29e0e206</gtr:id><gtr:otherNames>Viprakasit V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>694DAFD4EEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03C32CBA-8CA5-47C1-B4CB-1378DE985A41</gtr:id><gtr:title>Selective silencing of a-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>58b6af64c81418.65892648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B72FE7B2-9F4F-4CAC-8378-DA72114412A2</gtr:id><gtr:title>A new dawn for stem-cell therapy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>D27301EE917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C5110BE-CE14-401F-9B3F-9CB0F1969EB3</gtr:id><gtr:title>The alpha thalassaemias.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>AC70F26F212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AA01DB5-C038-489D-BCA7-4D190EF025CD</gtr:id><gtr:title>a-Globin as a molecular target in the treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d03d3b7b7b30.81065154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5135C28-FDEB-49A5-B1DB-BDB113C1D9FB</gtr:id><gtr:title>Chromosome looping at the human alpha-globin locus is mediated via the major upstream regulatory element (HS -40).</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f62bfcd0794a3cefbe9cae3c12f1a73e"><gtr:id>f62bfcd0794a3cefbe9cae3c12f1a73e</gtr:id><gtr:otherNames>Vernimmen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>A1913CA2DEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD6A0402-5D92-4B55-AE96-52283E6ECF64</gtr:id><gtr:title>An international registry of survivors with Hb Bart's hydrops fetalis syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a511347ce07fee54f2af7dab2b6ceb23"><gtr:id>a511347ce07fee54f2af7dab2b6ceb23</gtr:id><gtr:otherNames>Songdej D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5a994894b0a259.50551094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6530C524-6686-45E4-8A64-A72A9DE745EF</gtr:id><gtr:title>PhenCode: connecting ENCODE data with mutations and phenotype.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99ac403c7fa258a68b80b7fdbbec57e2"><gtr:id>99ac403c7fa258a68b80b7fdbbec57e2</gtr:id><gtr:otherNames>Giardine B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>D1C2B837749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23661CC1-E1CA-4068-9D42-8B45036B09A1</gtr:id><gtr:title>Beta thalassaemia intermedia due to co-inheritance of three unique alpha globin cluster duplications characterised by next generation sequencing analysis.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722f30aecd71f1a59c1ba6e08566ee25"><gtr:id>722f30aecd71f1a59c1ba6e08566ee25</gtr:id><gtr:otherNames>Clark B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>58b6af643bb9c8.12807708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A34342E2-C81A-4237-AC92-5B0E63516773</gtr:id><gtr:title>Robust detection of chromosomal interactions from small numbers of cells using low-input Capture-C.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a6f2de1316118.57486220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71715711-5CEB-4F9E-B4D0-692E2E8E03D5</gtr:id><gtr:title>Newborn Screening for Sickle Cell Disease: Jamaican Experience.</gtr:title><gtr:parentPublicationTitle>The West Indian medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e6fd9fb38995a694e6e0235e807ea2a"><gtr:id>2e6fd9fb38995a694e6e0235e807ea2a</gtr:id><gtr:otherNames>Mason K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0043-3144</gtr:issn><gtr:outcomeId>56d03d3d4451e8.23464677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09359B25-3239-4D10-BCD5-9DCAA1FFF944</gtr:id><gtr:title>Long-range regulation of alpha globin gene expression during erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Current opinion in hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1065-6251</gtr:issn><gtr:outcomeId>286A4F7EBE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24555117-9087-409C-83C0-CCDFA0E10CD4</gtr:id><gtr:title>Understanding a-globin gene regulation and implications for the treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>56d03d3ccc7693.50872447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66F6CB62-0112-4BCE-937F-80B29529394B</gtr:id><gtr:title>Editing an a-globin enhancer in primary human hematopoietic stem cells as a treatment for ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a994893441699.67498998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C712F98E-569A-4513-81EC-E86C53F80D63</gtr:id><gtr:title>Coregulated human globin genes are frequently in spatial proximity when active.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5972aac6e4f4128eb96dcaf53080fb8"><gtr:id>b5972aac6e4f4128eb96dcaf53080fb8</gtr:id><gtr:otherNames>Brown JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>2F0CB18CF04</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08EB315A-CB5B-4A5B-8FB6-2F28E00123AF</gtr:id><gtr:title>Functional characterisation of-regulatory elements governing dynamicexpression in the early mouse embryo.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b26b52cb6a8665efec9700003df5796"><gtr:id>7b26b52cb6a8665efec9700003df5796</gtr:id><gtr:otherNames>Simon CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5a994894487f32.08085946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BDCAFA2-EB82-4903-9E77-8B504BC762DF</gtr:id><gtr:title>Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6109abc8918bd3707eccb11a639910b3"><gtr:id>6109abc8918bd3707eccb11a639910b3</gtr:id><gtr:otherNames>Ahmed MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>316E37A672E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEC339F4-2B53-4F72-B608-7C78CFDE4EF3</gtr:id><gtr:title>Multiplexed analysis of chromosome conformation at vastly improved sensitivity.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69710e756a65a120cb06d94fec106efb"><gtr:id>69710e756a65a120cb06d94fec106efb</gtr:id><gtr:otherNames>Davies JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>56d03d3c70cab5.12018559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B282AB8-F12E-4AC5-ADB0-C6E3BCF92506</gtr:id><gtr:title>Long-range regulation of alpha-globin gene expression.</gtr:title><gtr:parentPublicationTitle>Advances in genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0065-2660</gtr:issn><gtr:outcomeId>671BE8EAAF1</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137961144</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>